Caris Life Sciences’ scientific experts and external collaborators are contributing to major advances in the understanding of blood-based circulating microvesicles (cMV) and their potential utility to aid in the diagnosis, prognosis, and theranosis of cancer and other complex diseases. Posters and abstracts highlighting the promise of ADAPT Biotargeting Systemâ„¢ are listed below.

Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach

Molecular Variances Between Rectal and Left-Sided Colon Cancers (Presentation)

Molecular Variances Between Rectal and Left Sided Colon Cancers

Molecular characterization of squamous cell carcinoma of the anal canal (SCCA)

Molecular Characterization of Early vs. Late Onset Gastroesophageal Cancer

Characterization of Tumor Mutation Burden (TMB) in Gastrointestinal (GI) Cancers

Racial differences in the molecular landscape of breast cancer

Use of an aptamer library based next generation omics platform for the development of a novel trastuzumab

Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) distribution in triple negative breast cancer TNBC

ESR1 mutations, ESR1 fusions and co-occurring alterations assessed in breast cancer tumors